Search by Drug Name or NDC

    NDC 71336-1003-01 AMVUTTRA 25 mg/.5mL Details

    AMVUTTRA 25 mg/.5mL

    AMVUTTRA is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is VUTRISIRAN.

    Product Information

    NDC 71336-1003
    Product ID 71336-1003_0a7f82da-c2c4-4e6d-8708-15d128b6a460
    Associated GPIs 6270609010E520
    GCN Sequence Number 083481
    GCN Sequence Number Description vutrisiran sodium SYRINGE 25MG/0.5ML SUBCUT
    HIC3 P9B
    HIC3 Description AMYLOIDOSIS AGENTS-TRANSTHYRETIN (TTR) SUPPRESSION
    GCN 52467
    HICL Sequence Number 048059
    HICL Sequence Number Description VUTRISIRAN SODIUM
    Brand/Generic Brand
    Proprietary Name AMVUTTRA
    Proprietary Name Suffix n/a
    Non-Proprietary Name VUTRISIRAN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/.5mL
    Substance Name VUTRISIRAN
    Labeler Name Alnylam Pharmaceuticals, Inc.
    Pharmaceutical Class Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC], Transthyretin-directed RNA Interaction [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215515
    Listing Certified Through 2024-12-31

    Package

    NDC 71336-1003-01 (71336100301)

    NDC Package Code 71336-1003-1
    Billing NDC 71336100301
    Package 1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2022-06-13
    NDC Exclude Flag N
    Pricing Information N/A